In the polymerase chain reaction (PCR), a thermostable DNA polymerase amplifies DNA that is flanked by known sequences. The known sequences correspond to those on synthetic oligonucleotide primers which are used to initiate the reaction. PCR can be used in many complex ways to achieve different results.
General Issues to Consider:
Because PCR is very sensitive, product contamination by undesired sequences is problematic. Every effort must made to keep the template free of contaminating, especially previously amplifie d, sequences. Leave the DNA in the refrigerator until all the other reagents are mixed and aliquoted in the reaction tubes. Wear gloves when handling DNA template and PCR reaction mixtures. It is usually easier to make a master mix of everything (including the enzyme - it''s thermal stable) except the template. Aliquot the mixture into tubes, and add the template just prior to putting them in a thermal cycler. Other precautions include the use of cotton plugged pipet tips to reduce aerosol contaminants of amplified products, and separating initial templates from amplified DNA in separate rooms. Negative template controls should be included in all amplifications.
One of the most critical factors for successful amplification of DNA is the magnesium ion concentration. Too much MgCl2 will cause high levels of non-specific amplification, while too little will inhibit the reaction. This protocol uses 1.5 mM Mg++ as the final concentration for Taq DNA polymerase. Use this as a starting point when using previously untested primers and templates. Optimal concentrations may vary from 0.5 to 6 mM and are determined by titration with MgCl2. Because of this variation, 10X stock solutions frequently have no magnesium in them and the MgCl2 is added separately. Generally, the dNTP and MgCl2 concentrations are simultaneously adjusted.
Annealing temperatures are critical and may also require experimental optimization. Low temperature annealing increases non-specific amplification; high temperatures inhibit annealing but may increase specificity. Typical reactions are performed in a range of 55° to 65°C. The temperature optimum for Taq DNA polymerase is 72°C.
Choice of Primers:
A number of considerations go into designing primers. Primers should not be self-complementary or complementary to each other, especially at their 3'' ends to avoid primer-dimers from forming. Keep the G+C content between 40 and 60%. Avoid long stretches of G+C since they may form secondary structures. Addition of restriction enzyme sites to the 5'' end of the primers serve as useful vehicles for subsequent subcloning.
Primer concentrations should be in excess of the template throughout the cycling. Typically the primers are used over a 0.1 - 1.0 μM range. Lower concentrations may reduce artifacts and formation of primer-dimers.
Choice of Templates:
We have successfully used a variety of different templates in amplification reactions. Most human DNA preparations are from fresh peripheral blood leukocytes or cell lines. The cells are lysed, treated with proteanase-K, RNAase-treated, and phenol extracted. The final A260:280 ratio is about 1.8. For amplification of portions of plasmids, we have used everything from CsCl-banded DNA, quick prep DNA, and heat denatured, transformed bacteria. In the latter case, a single bacterial colony (or as small a portion of a frozen stock as possible) was added to 0.5 ml of TE, vortexed, and then centrifuged to pellet the bac teria. The pellet was resuspended or washed once in 100 μl of TE, centrifuged again, and resuspended in 10 μl of TE. The entire sample was added as the DNA template to a total 50 μl reaction volume.
Choice of DNA Polymerases:
Taq DNA Polymerase - Taq has 5'' to 3'' exonuclease activity, but neither 3'' to 5'' exonuclease nor any endonuclease activity. Its half-life at 95°C is 35-40 minutes, and is 10 minutes at 97.5°C. Molecular weight = 94,000 by SDS-PAGE. GeneAmp 10X PCR buffer II" from Perkin-Elmer Cetus is 500 mM KCl and 100 mM Tris-HCl (pH 8.3). Buffer I had 15 mM MgCl2 added to it. We dilute the 10X buffer in H2O; Perkin-Elmer recommends 0.15% NP-40, 0.15% tween-20, 0.1 mM EDTA and 25 mM Tris-HCl, pH 8.3 for AmpliTaq buffer.
Stoffel fragment - The N-terminal 289 amino acids of Taq were removed to reduce the 5'' to 3'' exonuclease activity. Its half-life at high temperatures is about twice that of Taq DNA polymerase. MgCl2 concentrations are typically 2-10 mM giving it a broader range of magnesium than Taq. The enzyme is recommended for allele specific PCR, and for amplification of regions with high GC content.
rTth DNA Polymeras e - This polymerase is used in reverse transcription-PCR where cDNA is first synthesized at 55° - 70°C in the presence of manganese. The buffer contains DMSO and glycerol. One version of this enzyme (rTth DNA polymerase XL) has proofreading activity via its 3'' to 5'' exonuclease activity and is used to generate longer PCR products. Promega states that polymerases with proof reading activities require higher primer concentrations (0.1 - 0.5 μM). The half-life of rTth DNA polymerase is a bout half that of Taq DNA polymerase.
UlTma DNA Polymerase - has 3'' to 5'' exonuclease, but not 5'' to 3'' exonuclease activity. Its half-life at 97.5°C is 40-50 minutes. 10X Buffer from Perkin-Elmer for this enzyme is 100 mM Tris-HCl, pH 8.8, 100 mM KCl, and 0.02% tween 20. It is used at 2-6 U/100 μl reaction volume. Its fidelity may be higher than other enzymes.
Setting up the Reaction:
For a Single 100 μl PCR Reaction:
10x PCR buffer 10.0 μl
dNTP mixture (1.25 mM each dNTP) 16.0 μl (final concentration = 200 μM each)
5'' primer ( 20 μM) 5.0 μl (final concentration = 1.0 μM)
3'' primer (20 μM) & nbsp; 5.0 μl (final concentration = 1.0 μM)
Taq DNA polymerase (5 U/μl stock) 0.5 μl (2.5 units)
DNA template &nbs p; varies (0.1 to 1.0 μg for genomic DNA;
1 ng or less for cloned or amplified DNA)
Ste rile Water to 100 μl
Layer 50 - 75 μl of mineral oil on top of reaction mixture.
Sample volumes vary between 25 and 100 μl. Smaller volumes are possible, but larger volumes may reduce yields, perhaps because of the additional time needed to bring the sample to proper temperature. Variation in the concentration of some of the components is acceptable. For example, we have successfully amplified 300 bp regions with 25 μM dNTPs. Primer concentrations may also be reduced to 0.1 μM.
As described above, a "master mix" may be prepared for amplification of DNA in multiple tubes. The following table gives volumes (in μl) for preparation of a master mixture for 1 through 10 reactions of 25 &# 181;l per tube. A slight excess is prepared to provide sufficient volumes for pipeting.
Cycling Parameters:
To reduce nonspecific amplification, increase the annealing temperature in 3 to 5°C increments. We have used the extension temperature without a separate annealing temperature for particular amplifications with good results.
"Hot starts" refer to the addition of the polymerase after the DNA has denatured. This should result in minimizi ng nonspecific priming at low temperatures. This is accomplished by heating the sample above the denaturing temperature and then adding the Taq DNA polymerase through the mineral oil layer into the aqueous solution containing the DNA. Wax plugs are also commercially available. They are melted above the sample (lacking polymerase) then allowed to harden at room temperature. Additional reagents can be added above the solid wax (i.e. Taq polymerase), and then the entire sample is added to the thermal cycle r. As the DNA is denatured and the wax melts, the enzyme transfers to the sample to begin amplification.
A typical cycling temperature profile is:
94°C for 1 minute
60°C for 1 minute
72°C for 1 minute
We use a 5 minutes time period at 94°C to denature template prior to the initial cycle. An old rule of thumb for a 72°C extension temperature is 1 minute for each 1000 base pairs of DNA being amplified. A 2 kb segment would need an extra minute, while segments under 200 bp don''t need an extension plateau. More recently, Perkin Elmer Cetus has reported the extension rates for Taq, Stoffel and rTth polymerases are 2 - 4 kb per minute. Taq DNA polymerase is active over a broad range, not just at the extension temperature. A Perkin-Elmer representative said that they ha ve measured elongation rates of 75 bp/second at 70°C, 24 bp/sec at 55°C, and 1.5 bp/sec at 35°C. Thus, extension occurs throughout the annealing step, further stabilizing the primer-template interactions, but increasing nonspecific products. A final 5 minute incubation at 75#176;C is commonly added at the end of the cycles.
Cloning Amplified Products:
The ligation efficiency of amplified DNA varies from sequence to sequence. The cause of the problem is either addition of an A at the end of PCR products, and/or Taq polymerase enzyme remaining on the end of the DNA after amplification. Various solutions have been devised to compensate for these problems.
Perhaps the simplest strategy when you know in advance that you are going to clone the products is to design a restriction enzyme site(s) to the 5'' end of the primers. Be sure these are unique to the primers and are not also present on the sequence you are amplifying. The products are then digested and subcloned into an appropriately digested vector. Note that some enzymes need a certain number of nucleotides beyond their recognition site for digestion.
In "Improved Cloning Efficiency of Polymerase Chain Reaction (PCR) Products after Proteinase K Digestion" by Crowe et al (1991) Nucl. Acids. Res.19(1):184, the authors conclude that T aq polymerase sticks to the ends of amplified products. They found that proteinase K treatment increased the yield of their clones.
Vectors are commercially available that have an overhanging T on them to compensate for the potential overhanging A at the end of some PCR products. We have had many successful ligations of PCR products into blunt-end digested vectors, suggesting that there is a significant proportion of molecules that lack the overhang ing A residue. Others have treated their products for 15 minutes with 10 U of T4 DNA polymerase, or 30-60 minutes with 5-10 units of Klenow to produce blunt end products. For an alternate strategy, see Aslanidis and de Jong, Nucleic Acids Research 18:6069-6074. The method does not use ligation, and reportedly produces only recombinants with high efficiency. Small inserts can give light blue colonies when a pUC-based vector is employed.
Product Fidelity:
; Mutation estimates vary from 10-3 to10-5 and vary with the length of the product and the number of cycles. Other parameters have also been found that influence this measurement. To maximize sequence fidelity of the products, or for use in random mutagenesis, the following table may be helpful.
Stock Reagent | 1x | 2x | 3x | 4x | 5x | 6x | 7x | 8x | 9x | 10x |
---|---|---|---|---|---|---|---|---|---|---|
25 mM MgCl2 (1.5mM final) | 1.5 | 3.45 | 4.95 | 6.45 | 7.95 | 10.5 | 12 | 13.5 | 15 | 16.5 |
2.5 | 5.75 | 8.25 | 10.75 | 13.25 | 17.5 | 20 | 22.5 | 25 | 27.5 | |
1 mM ATP & nbsp; (100 mM final) | 2.5 | 5.75 | 8.25 | 10.75 | 13.25 | 17.5 | 20 | 22.5 | 25 | 27.5 |
1 mM GTP (100 mM final) | 2.5 | 5.75 | 8.25 | 10.75 | 13.25 | 17.5 | 20 | 22.5 | 25 | 27.5 |
1 mM TTP (100 mM final) | 2.5 | 5.75 | 8.25 | 10.75 | 13.25 | 17.5 | 20 | 25 | 27.5 | |
1 mM CTP (100 mM final) | 2.5 | 5.75 | 8.25 | 10.75 | 13.25 | 17.5 | 20 | 22.5 | 25 | 27.5 |
OR -- for labelling DNA substitute above dCTP with: | ||||||||||
1 mM dCTP (cold) | 2.1 | 4.83 | 6.93 | 9.03 | 11.13 | 14.7 | 16.8 | 18.9 | 21 | 23.1 |
32P-dCTP (4μCi) | 0.4 | 0.92 | 1.32 | 1.72 | 2.12 | 2.8 | 3.2 | 3.6 | 4 | 4.4 |
---------------------------- | ||||||||||
Water | 0.7 | 1.61 | 2.31 | 3.01 | 3.71 | 4.9 | 5.6 | 6.3 | 7 | 7.7 |
20 μM 5'' primer (1 μM final) | 1.25 | 2.875 | 4.125 | 5.375 | 6.625 | 8.75 | 10 | 11.25 | 12.5 | 13.75 |
20 μM 3'' primer (1 μM final) | 1.25 | 2.875 | 4.125 | 5.375 | 6.625 | 8.75 | 10 | 11.25 | 12.5 | 13.75 |
Taq Polymerase (5U/μl) (1.5U) | 0.3 | 0.69 | 0.99 | 1.29 | 1.59 | 2.1 | 2.4 | 2.7 | 3.0 | 3.3 |
SUM | 17.5 | 40.25 | 57.75 | 75.25 | 92.7 5 | 122.5 | 140 | 157.5 | 175 | 192.5 |
DNA template: Q.S. with H20 to 7.5 μl | Dispense 17.5 μl of master mix per tube. Add 7.5 μl of DNA to bring final volume to 25 μl. Overlay with 50 μl of mineral oil. |
Component | Increased Fidelity | Increased Infidelity |
---|---|---|
dNTP | Equal concentrations of dNTPs @ 40-50μM each | Unequal concentrations, 1-2 mM of 3 dNTPs with 0.1 - 0.2 mM of the fourth |
Mg++ | 1 - 1.5 mM | 6 - 8 mM with 0.5 mM Mn ++ |
Temperature | increase | decrease |
[Taq] | decrease | increase |
Time | decrease extension time | increase extension time< /TD> |
# cycles | decrease | increase |
Problem Solving Section:
(1) No or few products detected
Were all components added?
Was the template denatured?
Are the primers annealing and forming primer dimers?
Are the cycling parameters correct, i.e. low enough for annealing and extension?
項目概況2024年度攻堅第十二批醫療設備采購項目(1-5包)招標項目的潛在投標人應在通利晟信管理咨詢有限公司3樓(大連市沙河口區萬歲街135號)獲取招標文件,并于2024年10月09日09點30分(北...... 根據全國公共資源交易平臺公示,上海中醫藥大學附屬曙光醫院數字PCR系統等項目中標(成交)結果公布。其中,數字PCR系統的中標供應商為上海捷譜儀器設備有限公司,中標金額為1098500.00元。該公司的...... 2024年9月3日,上海中醫藥大學附屬曙光醫院數字PCR系統等項目中標(成交)結果公布。其中,數字PCR系統的中標供應商為上海捷譜儀器設備有限公司,中標金額為1098500.00元。該公司的投標文件無...... 書接上回,PCR市場如何?本網進行了數據整理,意在為各位讀者提供參考。上篇文章中提到近期PCR儀新品及上市情況(2024PCR儀市場亮點:國械注準新動態與前沿新品概覽),共計20款儀器問世,各廠商都在...... 近期,14所高校發布采購計劃,均超千萬,總額超21億,主要集中在8月份采購,包括質譜、光譜、色譜等多種儀器,具體如下:序號高校總預算(元)采購時間1華東師范大學952979508月2中國科學技術大學9...... 6月18日,鼎晶生物與臻準生物就數字PCR合作的未來方向達成共識,并對ESR1的項目研發、市場推廣達成戰略合作意向。此次,鼎晶生物聯合臻準生物推出新產品“人ESR1基因突變檢測試劑盒(數字PCR法)”...... 在2024年的第一季度至第二季度期間,多家生物科技與醫療設備企業的PCR儀產品成功獲得了國家藥品監督管理局(NMPA)頒發的《醫療器械注冊證》,標志著這些創新產品正式獲批并進入市場。具體包括:新羿生物...... 為便于供應商及時了解政府采購信息,根據《財政部關于開展政府采購意向公開工作的通知》(財庫〔2020〕10號)等有關規定,現將太原市第三人民醫院2024年5月至6月采購意向公開如下:序號采購項目名稱采購...... 項目概況新疆維吾爾自治區農業科學研究院園藝作物研究所實驗室儀器設備采購項目招標項目的潛在投標人應在政采云平臺線上獲取招標文件,并于2024年05月27日11:00(北京時間)前遞交投標文件。一、項目基...... 一、項目基本情況項目編號:GDYD240133項目名稱:呼吸道多重(23重)病原體核酸檢測試劑盒(熒光PCR法)采購方式:公開招標預算金額:1,904,400.00元采購需求:合同包1(呼吸道多重(2......其他網友還關注過
預算近716萬某部醫院PCR分析儀、顯微鏡等設備招標采購
110萬,上海捷譜儀器中標上海中醫藥大學附屬曙光醫院數字PCR系統
109萬,上海捷譜中標上海中醫藥大學附屬曙光醫院數字PCR系統
盛景不再?2024上半年PCR中標盤點,三家成交額超千萬
21.2億|14所高校采購計劃出爐,哪些儀器被選中?
鼎晶生物和臻準生物就ESR1數字PCR項目達成戰略合作
2024PCR儀市場亮點:國械注準新動態與前沿新品概覽
500萬,該醫院計劃采購質譜及PCR系統
超60臺,該研究所實驗室儀器設備采購項目公開招標
190萬這類核酸檢測試劑盒(熒光PCR法)招標